CRBU
Price
$4.96
Change
-$0.13 (-2.55%)
Updated
Sep 25, 6:59 PM EST
42 days until earnings call
FULC
Price
$4.20
Change
+$0.03 (+0.72%)
Updated
Sep 25, 6:59 PM EST
50 days until earnings call

Compare trend and price CRBU vs FULC

Header iconCRBU vs FULC Comparison
Open Charts CRBU vs FULCBanner chart's image
Caribou Biosciences
Price$4.96
Change-$0.13 (-2.55%)
Volume$996.91K
CapitalizationN/A
Fulcrum Therapeutics
Price$4.20
Change+$0.03 (+0.72%)
Volume$273.09K
CapitalizationN/A
View a ticker or compare two or three
CRBU vs FULC Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CRBU vs. FULC commentary
Sep 26, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FULC is a Hold.

COMPARISON
Comparison
Sep 26, 2023
Stock price -- (CRBU: $4.96 vs. FULC: $4.20)
Brand notoriety: CRBU and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 103% vs. FULC: 17%
Market capitalization -- CRBU: $449.37M vs. FULC: $257.8M
CRBU [@Biotechnology] is valued at $449.37M. FULC’s [@Biotechnology] market capitalization is $257.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRBU and FULC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while FULC’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 5 bearish.
  • FULC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than FULC.

Price Growth

CRBU (@Biotechnology) experienced а -5.61% price change this week, while FULC (@Biotechnology) price change was -3.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.83%. For the same industry, the average monthly price growth was +22.16%, and the average quarterly price growth was +34.16%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 07, 2023.

FULC is expected to report earnings on Nov 15, 2023.

Industries' Descriptions

@Biotechnology (-3.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRBU with price predictions.
OPEN
A.I.dvisor published
a Summary for FULC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRBU($449M) has a higher market cap than FULC($258M). CRBU YTD gains are higher at: -21.019 vs. FULC (-42.308). FULC has higher annual earnings (EBITDA): -104.8M vs. CRBU (-118.94M). FULC has more cash in the bank: 278M vs. CRBU (259M). FULC has less debt than CRBU: FULC (12.2M) vs CRBU (27.2M). CRBU has higher revenues than FULC: CRBU (14.3M) vs FULC (3.04M).
CRBUFULCCRBU / FULC
Capitalization449M258M174%
EBITDA-118.94M-104.8M113%
Gain YTD-21.019-42.30850%
P/E RatioN/AN/A-
Revenue14.3M3.04M470%
Total Cash259M278M93%
Total Debt27.2M12.2M223%
TECHNICAL ANALYSIS
Technical Analysis
CRBUFULC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSPFX6.270.05
+0.80%
Transamerica Small Cap Growth R4
PEIZX20.000.10
+0.50%
PGIM Jennison Value Z
PFRSX24.56-0.02
-0.08%
Principal Real Estate Securities Fd R-6
BRZAX9.97-0.04
-0.40%
BlackRock Sus Adg Intl Eq Inv A
FNGRX13.83-0.06
-0.43%
Franklin Intl Growth R

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with PMVP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then PMVP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-2.55%
PMVP - CRBU
52%
Loosely correlated
-2.04%
AXON - CRBU
50%
Loosely correlated
-1.12%
MDGL - CRBU
49%
Loosely correlated
-1.57%
EDIT - CRBU
49%
Loosely correlated
-9.49%
SGMO - CRBU
46%
Loosely correlated
-10.14%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with NKTR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then NKTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+0.72%
NKTR - FULC
49%
Loosely correlated
-0.58%
SLS - FULC
47%
Loosely correlated
+1.32%
SRNEQ - FULC
34%
Loosely correlated
+0.84%
AXON - FULC
33%
Poorly correlated
-1.12%
SGMO - FULC
33%
Poorly correlated
-10.14%
More